Table 1. Studies that employed salivary samples for molecular detection of novel corona virus.
No. | Study hypothesis | Study findings/ conclusion | Author and year of publication |
---|---|---|---|
1 | Salivary testing from suspected COVID-19 patients based on clinical and epidemiological criteria. | nCoV was detected in the self-collected saliva of 91.7% of patients. | To et al 2020 5 |
2 | Ferret model of SARS-COV-2 study employed to understand the infection and transmission that recapitulates aspects of human disease. | SARS COV-2 infected ferrets showed the presence of the virus in nasal washes and saliva up to 8 days postinfection. | Kim et al 2020 8 |
3 | Analysis of COVID-19 from salivary samples of patients with known clinical and laboratory data. Samples were collected from patients with severe to very severe COVID-19 symptoms. | All the samples tested positive for nCoV. Interestingly, two patients showed positive salivary results while nasal swabs were negative. | Azzi et al 2020 9 |
4 | Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission. | Oral-saliva and oral-urine routes are also a possibility for viral transmission. | Goh et al 2013 10 |
5 | Viral replication in the upper respiratory tract may contribute to the rapid viral shedding into saliva droplets. | Demonstrated for the first time in the literature that the ACE2 epithelial cells of the salivary gland ducts are early targets of SARS-CoV infection. The findings provide evidence that salivary gland epithelial cells can be infected in vivo soon after infection, thus providing source of virus in saliva, particularly in early infection. | Liu et al 2011 4 |
Abbreviations: ACE2, angiotensin-converting enzyme 2; COVID-19, coronavirus disease 2019; HCoV-EMC, Human Corona Virus-Eramus Medical Center; MERS-CoV, Middle East respiratory syndrome-coronavirus, nCoV, novel coronavirus; SARS-CoV, severe acute respiratory syndrome-coronavirus.